drugset / Trial / NCT02729012

Effects of Hypertonic Saline Solution (NACL 3%+NAHCO3) on Nasal Inflammation in Children With AR. RinASol- Pilot Study

NCT02729012 ↗

Phase 4 Completed 30 enrolled Stefania La Grutta, MD
RandomizedParallel-groupOpen-labelTreatment

Summary

The main objective of RinASol project is to assess in patients with seasonal Allergic Rhinitis the effect of hypertonic saline solution NACL 3%+NAHCO3 vs the effect of standard saline solution on nasal inflammation by means of nasal cytology. The secondary objective is the symptom score assessment by T5SS Questionnaire (Total Symptom Score 5)

Timeline

Start
2015-10
Primary completion
2016-06
Completion
2016-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator hypertonic saline solution Unknown 3 % Inhaled

Indications